Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for opioid-induced hyperalgesia in opioid-addicted adults
IRCT20211112053045N1Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of memantine in opioid-induced hyperalgesia (OIH) (2 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoints: Pain severity score and Cold pressor tolerance time. Started Dec 2021; status: completed.
02
Drugs
memantine
03
Conditions
opioid-induced hyperalgesia (OIH)
Beyond the preview
Go deeper on IRCT20211112053045N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211112053045N1.